-

Claritev Corporation Announces Participation at Upcoming Conferences

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced that members of its management team will participate in person at the following conferences in December 2025:

  • BofA Securities Leveraged Finance Conference – Tuesday, December 2, 2025, at The Boca Raton, Boca Raton, FL (including a presentation at approximately 7:30 am Eastern Time)
  • Citi’s 2025 Global Healthcare Conference – Wednesday, December 3, 2025, at the Intercontinental Miami, Miami, FL
  • Piper Sandler 37th Annual Healthcare Conference – Thursday, December 4, 2025, at the Lotte New York Palace, New York, NY (including a fireside chat at 8:00 am Eastern Time)

Where available, a live webcast and audio archive of the events will be available through the investor relations section of Claritev’s website at investors.claritev.com/events-and-presentations. For one-on-one meetings, please contact a representative at the host firms.

About Claritev

Claritev is a healthcare technology, data and insights company focused on improving affordability, transparency, and quality. Led by a team of deeply experienced associates, data scientists and innovators, Claritev provides tech-enabled solutions and services fueled by multiple data sources and over 40 years of claims repricing experience. Claritev utilizes world-class technology and AI solutions to power a robust enterprise platform that delivers meaningful insights to drive affordability and price transparency and optimizes networks and benefits design. By focusing on purpose-built solutions that support all key players —including payors, employers, patients, providers and third parties—Claritev aims to make healthcare more accessible and affordable for all.

Claritev serves more than 700 healthcare payors, over 100,000 employers, 60 million consumers, and 1.4 million contracted providers. For more information, visit claritev.com.

Contacts

Investor Relations Contact
Todd Friedman
VP, Investor Relations
Claritev
866-909-7427
investor@claritev.com

Media Relations
Pam Walker
VP, Marketing and Communication
Claritev
781-895-3118
press@claritev.com

Claritev Corporation

NYSE:CTEV
Details
Headquarters: McLean, VA
CEO: Travis Dalton
Employees: 2800
Organization: PUB

Release Summary
Claritev Corporation Announces Participation at Upcoming Conferences
Release Versions

Contacts

Investor Relations Contact
Todd Friedman
VP, Investor Relations
Claritev
866-909-7427
investor@claritev.com

Media Relations
Pam Walker
VP, Marketing and Communication
Claritev
781-895-3118
press@claritev.com

More News From Claritev Corporation

Claritev Corporation Announces Pricing of Offering of Class A Common Stock by Selling Stockholders

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced the pricing of an underwritten public offering (the “Offering”) of 1,500,000 shares of its Class A common stock, par value $0.0001 per share (the “Class A common stock”), by certain affiliates of Hellman & Friedman (collectively, the “Selling Stockholders”) at a price...

Claritev Corporation Announces Public Offering of Class A Common Stock by Selling Stockholders

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data and insights company focused on making healthcare more affordable, transparent and fair for all, today announced the commencement of an underwritten public offering (the “Offering”) of 1,500,000 shares of its Class A common stock, par value $0.0001 per share (the “Class A common stock”), by certain affiliates of Hellman & Friedman (collectively, the “Selling Stockholders”). The...

Claritev Corporation Reports Third Quarter 2025 Results

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation Reports Third Quarter 2025 Results...
Back to Newsroom